INTRODUCTION
T hyroid carcinoma (TC) is rare in children, particularly those aged < 10 years, and accounts for 1.5%-3% of all childhood cancers in North America and Europe; however, its incidence has been increasing by 1.1% each year (1) . In Brazil, according to the National Cancer Institute database, the incidence of TC may be 2% of all pediatric cancers (2) . The behavior of TC in children aged < 10 years differs from that in adults, because in the pediatric range there is usually at least one risk factor for papillary TC (PTC), mainly ionizing radiation exposure and family history (3) .
Several studies have revealed the correlation between neoplasms and hyperinsulinemia and insulin resistance (IR), which are frequently associated with a higher risk for and/or aggressiveness of the neoplasm (4) (5) (6) . However, many of those studies included subjects who were obese, which characterizes many confounding variables (6) (7) (8) , and data in conditions of severe IR are lacking. CGL is a rare disease with autosomal recessive inheritance characterized by a lack of adipose tissue, hypoleptinemia, severe IR, and early metabolic disturbances such as dyslipidemia and diabetes mellitus (9, 10) .
Here, we report a rare case of type 2 CGL in a girl who presented with PTC at the age of 7 years and who had no family history of TC or previous exposure to ionizing radiation.
CASE REPORT
A 9-year-old girl with a clinical and molecular diagnosis of CGL was being followed at our center, (BRAZLIPO Program, Endocrine and Diabetes Unit, University Hospital, Federal University of Ceará, Brazil). Based on the generalized absence of adipose tissue, she was clinically diagnosed as having CGL in her first year of life.
A physical examination at 7 years of age revealed a height of 143 cm, a weight of 42.1 kg, and a body mass index (BMI) of 20.5 kg/m 2 . She had a generalized lack of subcutaneous fat, including in the palmar and plantar regions, muscle hypertrophy, intense acanthosis nigricans, and hepatomegaly ( Figure 1 ). The patient also had a history of consanguinity. Her parents are first-degree cousins, and her brother has the same clinical diagnosis of CGL (Figure 2) .
In her first year of life, hypertriglyceridemia (442 mg/dL) was detected. During follow-up, her clinical and laboratory work-up revealed IR (Table 1 ). At 7 years of age, fasting hyperinsulinemia, severe IR, abnormal glucose tolerance, and hypoleptinemia were also observed. At this time, a genetic analysis revealed a BSCL2 gene mutation (p.Thr109Asnfs* 5), characterizing type 2 CGL.
At 7 years of age, thyroid gland ultrasound revealed a hypoechoic solid nodule measuring 1.8 × 1.0 × 1.0 cm in size, with partially defined margins and multiple foci of microcalcification located in the upper third of the right lobe. According to the clinical history, the patient had no family history of TC or previous exposure to ionizing radiation.
Results of a cytological evaluation of the nodule, obtained through fine-needle aspiration biopsy, suggested malignancy (Bethesda V classification). Thus, total thyroidectomy was performed. Results of a histopathological examination confirmed a classical variant of PTC, with the tumor measuring 1.2 cm (unifocal) and having vascular invasion. Perineural infiltration was not performed. Extrathyroid extension and metastasis were observed in a parathyroid lymph node (pT3N1Mx stage) ( Figure 3 ). The patient also underwent radioiodine therapy (100 mCi), followed by suppressive levothyroxine treatment (3 mcg/kg/day), and no signs of residual disease. case of the association between DTC and IR was in a 13.5-year-old obese girl with acanthosis nigricans (17) . Diabetes and IR are considered risk factors for DTC (18) . Epidemiological studies have suggested the association, although in such studies only obese subjects were evaluated, possibly leading to the presence of a positive confounder (7, 19, 20) . A previous crosssectional study assessed the correlation between IR and thyroid, independent of body weight, in participants grouped according to their BMI and homeostasis model assessment-IR (HOMA-IR) and concluded that individuals with higher IR had a higher number of nodules and greater thyroid volume, independent of BMI (8).
Our patient had hyperinsulinemia since the 7 years of age. Insulin acts as a growth factor that stimulates cell proliferation. Some studies have described that insulin receptors (IRs) are overexposed in most DTC cases (21, 22) . In addition, insulin reduces insulinlike growth factor-binding protein levels, leading to increased levels of insulin-like growth factor (IGF), subsequently resulting in cell multiplication and apoptosis reduction. Insulin also increases the risk of mutations and cancer development (22) .
IGF-1 plays a role in various human malignancies and possibly in DTC (21, 22) . IGF-1 is important for thyroid growth and development, as thyroidstimulating hormone (TSH). In addition, IGFreceptors are overexpressed in DTC (21), which amplifies the anabolic effect on thyrocytes (23).
Some studies have described the presence of high leptin levels in patients with DTC (24) . Cheng and cols. demonstrated that leptin and leptin receptors are overexpressed in patients with PTC, which correlates with increased tumor aggressiveness (7). In contrast, our patient had very low leptin levels, which correlated to the absence of metabolic active adipose tissues.
Although our patient had no clinical diagnosis of diabetes, she had altered glycated hemoglobin levels. Most studies have demonstrated the correlation between diabetes and DTC. In their case-control study, Bae and cols. observed that Korean women in the upper quarters of HOMA-IR had an odds ratio of 4.07 (95% confidence interval [CI] 2.81-5.89, p < 0.001) for DTC. These data were adjusted for age, BMI, history of smoking, hypertension, thyroid disease, other cancers, cholesterol levels and TSH (25) .
In the meta-analysis conducted by Yeo and cols., women with pre-existing DM had an increased risk for 
RESULTS AND DISCUSSION
This is the first study to report about a differentiated TC (DTC) in a child with CGL. Although the patient did not present with other risk factors for TC, i.e., previous radiation exposure or a family history of TC, she had severe CGL-associated IR since early childhood. Furthermore, she had an aggressive presentation of PTC (pT3N1Mx stage). CGL is a rare congenital disorder that is characterized by total or near-total lack of body fat, low leptin levels, ectopic fat deposits, and severe metabolic disorders such as hypertriglyceridemia and IR (10) . Four subtypes of CGL have been described. Subtypes 1 and 2 are responsible for 95% of described cases and occur because of mutations in the AGPAT2 and BSL2 genes, respectively, which express proteins that are critical in triglyceride and phospholipid biosynthesis, lipid droplet formation, and adipocyte differentiation (11) . Low leptin and adiponectin levels, increased free fatty acids, and triglyceride depositions in the liver and skeletal muscles, which are associated with severe IR, are frequently noted (12) (13) (14) (15) .
CGL because of BSCL2 mutation is the most severe form of CGL, with a pronounced lack of adipose tissue (16) . It affects both the metabolic active and mechanical adipose tissues and usually results in earlier and more severe metabolic abnormalities. Mental retardation and cardiomyopathy have also been described (16) . Our patient presented with clinical and biochemical phenotypic characteristics of CGL.
She had hypertriglyceridemia and intense acanthosis nigricans since her first year of life. The first described TC (relative risk = 1.38, 95% CI 1.13-1.67) (26) . A similar conclusion was observed in another review that revealed that diabetes had a possible positive association with risk for TC (27) . Conversely, in a systematic review, Kitahara and cols. concluded that neither physical inactivity nor diabetes history was associated with an increased risk for TC (28) . These results are controversial, and evidence is not sufficient to associate RI or diabetes with TC (25, 29, 30) .
However, it is unlikely that the association reported here is a random occurrence. The occurrence of DTC in children aged < 10 years is rare and is usually associated with the presence of identifiable risk factors such as a family history and exposure to ionizing radiation during childhood; however, this was not observed in our patient. Our patient had IR since her first year of life, which was related to the most severe subtype of CGL. Our case findings reinforce the hypothesis that IR is a trigger for CGL, independent of BMI or leptin levels.
In conclusion, this is the first report to describe DTC in a child with CGL. The severe IR usually observed in this disorder early in life, especially type 2 of CGL, may be associated with the uncommon presentation of aggressive PTC during childhood. Future prospective studies are needed to better define the association between TC and severe IR and demonstrate the possible benefit of thyroid evaluation in patients with CGL.
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